Literature DB >> 24298475

Diabetic Profile- Screening of HBA1C - A Random Community Assessment.

M R Suchitra1, K Jaiganesh, S Parthasarathy.   

Abstract

BACKGROUND: Diabetes mellitus is becoming the commonest non-communicable disease in the world. Strict control of diabetes mellitus is associated with fewer incidences of complications. Screening for control of diabetes is a useful intervention, because diabetes is a highly morbid illness with a long asymptomatic phase. Glycosylated Haemoglob in (HbA1C) is the ideal parameter which can be used to assess the diabetic control, as this parameter is not alterable with single day manipulations. AIMS: Our main objective was to find out the mean HbA1C in a random assessment. The other supplementary objectives were to find out the prevalence of hypertension, smoking, obesity, vascular events and hypoglycaemic episodes and any possible correlation with HbA1C values.
METHODOLOGY: The selection of 100 diabetic patients who reported to the diabetic centre in a randomly selected day was done. They were subjected to a simple questionnaire with on spot HbA1c assessment. The questionnaire described the evidence of vascular events, risk factors, hypoglycaemic episodes, etc.
RESULTS: A mean HbA1C value of 8.91 was found out, which was far higher than the normal (7.0%). The prevalences of other variables coincided with those which were seen in previous studies. The hypoglycaemic episodes were high, but the patients with such episodes had a higher mean HbA1C. This could be possible as our patients consumed sweet and sugar with such events and had higher mean glucose values. It has been suggested that physicians and patients should work synchronously to achieve better diabetic control. The physician should strictly enforce weight reduction and quitting of smoking.

Entities:  

Keywords:  Community control; Diabetes mellitus; HbA1C; Hypoglycaemia

Year:  2013        PMID: 24298475      PMCID: PMC3843437          DOI: 10.7860/JCDR/2013/5690.3470

Source DB:  PubMed          Journal:  J Clin Diagn Res        ISSN: 0973-709X


  17 in total

1.  Limitations of glycosylated haemoglobin as an index of glucose intolerance.

Authors:  C Snehalatha; A Ramachandran; K Satyavani; V Vijay
Journal:  Diabetes Res Clin Pract       Date:  2000-02       Impact factor: 5.602

2.  Defining the relationship between plasma glucose and HbA(1c): analysis of glucose profiles and HbA(1c) in the Diabetes Control and Complications Trial.

Authors:  Curt L Rohlfing; Hsiao-Mei Wiedmeyer; Randie R Little; Jack D England; Alethea Tennill; David E Goldstein
Journal:  Diabetes Care       Date:  2002-02       Impact factor: 19.112

3.  Glucose-independent, black-white differences in hemoglobin A1c levels: a cross-sectional analysis of 2 studies.

Authors:  David C Ziemer; Paul Kolm; William S Weintraub; Viola Vaccarino; Mary K Rhee; Jennifer G Twombly; K M Venkat Narayan; David D Koch; Lawrence S Phillips
Journal:  Ann Intern Med       Date:  2010-06-15       Impact factor: 25.391

Review 4.  Cigarette smoking and diabetes.

Authors:  Björn Eliasson
Journal:  Prog Cardiovasc Dis       Date:  2003 Mar-Apr       Impact factor: 8.194

5.  Utility of HbA(1c) levels for diabetes case finding in hospitalized patients with hyperglycemia.

Authors:  Laura S Greci; Mala Kailasam; Samir Malkani; David L Katz; Ilja Hulinsky; Ramin Ahmadi; Haq Nawaz
Journal:  Diabetes Care       Date:  2003-04       Impact factor: 19.112

6.  A better level of HbA1c control achieved by family medicine teams, Bosnia and Herzegovina, by using diabetes mellitus type 2 recommended guidelines.

Authors:  Larisa Gavran; Selmira Brkić; Olivera Batic-Mujanović; Suad Sivić
Journal:  Med Glas (Zenica)       Date:  2011-08

Review 7.  Management of dyslipidemia in adults with diabetes.

Authors:  S M Haffner
Journal:  Diabetes Care       Date:  1998-01       Impact factor: 19.112

8.  International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes.

Authors: 
Journal:  Diabetes Care       Date:  2009-06-05       Impact factor: 17.152

9.  Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.

Authors: 
Journal:  Lancet       Date:  1998-09-12       Impact factor: 79.321

10.  The pros and cons of diagnosing diabetes with A1C.

Authors:  Enzo Bonora; Jaakko Tuomilehto
Journal:  Diabetes Care       Date:  2011-05       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.